Strengthen Compliance Programs and Business Intelligence with Industry Best Practices
August 11th, 2021
Earn CPE, CLE & CCB credits*
(*pending final approval)
Global life sciences organizations grapple every day with enormous risks related to bribery, corruption and fraud related to HCPs, HCOs and their supply chains more broadly, as evidenced by continued investigations and resolutions between companies and government regulators globally. Data analytics, specifically applying advanced algorithms to your company’s financial transactions, is a powerful new tool to prevent and detect fraud, corruption, and kickbacks. A company can deploy data analytics to continuously monitor 100% of transactions, globally, and entirely remotely and achieve far more effective risk management at less cost. Current and former in-house counsel and compliance professionals will walk through evolving regulator expectations around the use of data analytics and provide a practical roadmap for any sized company to implement advanced analytics and monitoring tools to support compliance, audit, investigations, the business, and the Board.